Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Study With ABBV-CLS-484 Alone and in Combination in Subjects With Locally Advanced or Metastatic Tumors

NCT04777994 is registered in ClinicalTrials.gov with Calico Life Sciences LLC as lead sponsor.

NCT NCT04777994
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04777994 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Study With ABBV-CLS-484 Alone and in Combination in Subjects With Locally Advanced or Metastatic Tumors
Lead sponsor
Calico Life Sciences LLC
Phase
Phase 1
Overall status
Recruiting
Start date
March 9, 2021
Completion date
October 31, 2026
Enrollment
248 (estimated)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumor cancer